Grivas P, Aragon-Ching JB, Bellmunt J, Loriot Y, et al. Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Analyses of Patient-reported Outcomes and Quality-adjusted Time Without Symptoms or Toxicity from the JAVELIN Bladder 100 Trial. Eur Urol Oncol 2025;8:941-951.
PMID: 40318950